NewAmsterdam, which reported another phase 3 win in July, plans to use the data to file for approval. However, as happened in ...

Dutch biotech NewAmsterdam Pharma (NASDAQ:NAMS) announced Wednesday that its oral anti-cholesterol therapy containing ...

Eli Lilly LLY announced that its investigational oral, once-daily cholesterol-lowering drug muvalaplin reduced lipoprotein(a) ...

Long-term use of cardiovascular drugs may reduce dementia risk in older adults by up to 25%, while antiplatelet drugs could ...

The cholesterol-lowering drug has been classed as a breakthrough therapy for homozygous familial hypercholesterolaemia (HoFH) by the FDA, which is due to deliver a decision on the marketing ...

AstraZeneca has bought rights to an orally-active drug that inhibits PCSK9, offering a patient-friendly alternative to current cholesterol-lowering therapies that have to be delivered via a needle.

Researchers have found that long-term use of drugs for hypertension and high cholesterol also lowers the risk of developing ...

Aug. 14, 2024 — More than a quarter of Australians over the age of 50 take cholesterol-lowering drugs to prevent heart disease and strokes, but our bodies also need cholesterol to survive.

Eli Lilly's muvalaplin Phase 2 trial showed significant Lp(a) reduction, meeting primary and secondary endpoints with ...

Monacolin K is a naturally occurring form of lovastatin. This drug lowers cholesterol. Red yeast rice extract has been shown to decrease LDL cholesterol between 15% and 25% in about two months.

Have you ever wondered why society is more focused on finding cures than on identifying causes? The answer is simple: there’s ...

QUESTION: Watch out for serious drug interactions with Preparation H! A few years ago, I was taking a beta blocker drug ...